Add Company
Join Now

Quincy Bioscience Revenue and Competitors

License our Company Data API

Madison, WI USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Quincy Bioscience's estimated annual revenue is currently $12.9M per year.(i)
  • Quincy Bioscience's estimated revenue per employee is $155,000

Employee Data

  • Quincy Bioscience has 83 Employees.(i)
  • Quincy Bioscience grew their employee count by 0% last year.

Quincy Bioscience's People

NameTitleEmail/Phone
1
VP Sales, eCommerce & Loss ControlReveal Email/Phone
2
Market Development DirectorReveal Email/Phone
3
Media DirectorReveal Email/Phone
4
Director Quality & ManufacturingReveal Email/Phone
5
Chief Financial OfficerReveal Email/Phone
6
Director Manufacturing SciencesReveal Email/Phone
7
Senior Financial Director and ControllerReveal Email/Phone
8
Senior Digital Marketing ManagerReveal Email/Phone
9
Information Technology ManagerReveal Email/Phone
10
Manufacturing & Quality Technical ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.8M1820%N/AN/A
#2
$1.9M1233%N/AN/A
#3
$1.1M70%N/AN/A
#4
$0.9M60%N/AN/A
#5
$5.2M670%$45.5MN/A
#6
$1.4M90%N/AN/A
#7
$1.6M100%N/AN/A
#8
$1.1M717%N/AN/A
#9
$13.5M87-17%N/AN/A
#10
$0.6M4-20%N/AN/A
Add Company

What Is Quincy Bioscience?

Quincy Bioscience is a biotechnology company based in Madison, Wisconsin, that focuses on the discovery, development and commercialization of novel technologies to support cognitive function and other normal health challenges associated with aging. Quincy Bioscience is set apart by its cutting-edge applications of apoaequorin which is breaking new ground with apoaequorin, originally discovered in jellyfish, now patented by Quincy Bioscience for use in a variety of products to support cognitive function. Apoaequorin is manufactured in a cGMP compliant facility. The discovery and development of apoaequorin in 1962 earned the scientists responsible great acclaim. Quincy Bioscience is building on this work through its novel use of apoaequorin. Apoaequorin achieved self-affirmed GRAS status (generally recognized as safe) after an independent panel of expert scientists concluded that apoaequorin is safe for use in food products. Prevagen® is the company's flagship consumer brand containing apoaequorin. A landmark double-blind and placebo-controlled trial demonstrated the ability to improve aspects of cognitive function in participants with either normal cognitive aging or very mild impairment, as determined by pre-trial screening. Prevagen is now the best-selling brain health supplement in chain pharmacies across America according to Nielsen data. Quincy Bioscience offers a competitive compensation package including: Health Insurance effective on first day of employment Dental, Vision, Life, Short-Term and Long-Term Disability Insurance Flex Spending 401(k) Paid Vacation

keywords:N/A

N/A

Total Funding

83

Number of Employees

$12.9M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Quincy Bioscience News

2022-04-06 - Brain Health Supplements Market Size is poised to exhibit a 8.5% CAGR by 2028 | AlternaScript, Accelerated

... Inc., Onnit Labs, LLC, Purelife Bioscience Co., Ltd., Quincy Bioscience, Cerebral Success, Amway, Puori, Ocean Health, and Schiff.

2022-03-30 - Neuriva's Brain Supplement, Plugged By Jeopardy Co-Host ...

The Neuriva settlement follows a similar agreement last year between consumers and Quincy Bioscience's Prevagen products that resulted in...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35M832%N/A
#2
$20.8M835%N/A
#3
$35M839%N/A
#4
$22.4M83-1%N/A
#5
$17M84-2%N/A